Aegerion Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - CONSENT OF L.E.K. CONSULTING, LLC - June 16, 2011

Attached files

file filename
S-1 - FORM S-1 - Aegerion Pharmaceuticals, Inc.ds1.htm
EX-5.1 - OPINION OF GOODWIN PROCTER LLP - Aegerion Pharmaceuticals, Inc.dex51.htm
EX-23.2 - CONSENT OF ERNST & YOUNG LLP - Aegerion Pharmaceuticals, Inc.dex232.htm

Exhibit 23.1

Consent of L.E.K. Consulting LLC

L.E.K. Consulting LLC (“L.E.K.”) hereby consents to the use of L.E.K.’s name and the statements attributed to L.E.K. in the Registration Statement of Aegerion Pharmaceuticals, Inc. on form S-1, dated June 16, 2011 (and any amendments thereto), provided that any modifications to the use of L.E.K.’s name or the statements attributed to L.E.K. in such Registration Statement shall be subject to the prior consent of L.E.K.

 

L.E.K. CONSULTING LLC
By:   /s/ Shuba Satyaprasad

Name:

   Shuba Satyaprasad

Title:

   General Counsel

 

  Date:       June 15, 2011
   Boston, MA

 

Aegerion Pharmaceuticals, Inc. Reports